Assess a series of important considerations for comanagement of HIV/HCV infection and opioid use disorder (OUD), including the high level of compatibility between HIV and/or HCV treatment regimens and medications for the treatment of OUD, the impact of comorbid stimulant use among patients with OUD, recognition of OUD as a chronic relapsing disorder that often requires treatment reinitiation, and the challenges of pain management for individuals with OUD.
Sandra Springer, MD
Christian B. Ramers, MD, MPH
Released: February 6, 2020Expiration: No longer available for credit
This program is divided into several short segments which you can step through using the Video Chapters widget.